Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline von Armenian, Saro H, Lacchetti, Christina, Barac, Ana, Carver, Joseph, Constine, Louis S, Denduluri, Neelima, Dent, Susan, Douglas, Pamela S, Durand, Jean-Bernard, Ewer, Michael, Fabian, Carol, Hudson, Melissa, Jessup, Mariell, Jones, Lee W, Ky, Bonnie, Mayer, Erica L, Moslehi, Javid, Oeffinger, Kevin, Ray, Katharine, Ruddy, Kathryn, Lenihan, Daniel

Volltext

Multidisciplinary Recommendations Regarding Post-Vaccine Adenopathy and Radiologic Imaging: Radiology Scientific Expert Panel von Becker, Anton S., Perez-Johnston, Rocio, Chikarmane, Sona A., Chen, Melissa M., El Homsi, Maria, Feigin, Kimberly N., Gallagher, Katherine M., Hanna, Ehab Y., Hicks, Marshall, Ilica, Ahmet T., Mayer, Erica L., Shinagare, Atul B., Yeh, Randy, Mayerhoefer, Marius E., Hricak, Hedvig, Vargas, H. Alberto

Volltext

Advances in Targeting Src in the Treatment of Breast Cancer and Other Solid Malignancies von MAYER, Erica L, KROP, Ian E

Volltext

Single duplex DNA sequencing with CODEC detects mutations with high sensitivity von Bae, Jin H., Liu, Ruolin, Roberts, Eugenia, Nguyen, Erica, Tabrizi, Shervin, Rhoades, Justin, Blewett, Timothy, Xiong, Kan, Gydush, Gregory, Shea, Douglas, An, Zhenyi, Patel, Sahil, Cheng, Ju, Sridhar, Sainetra, Liu, Mei Hong, Lassen, Emilie, Skytte, Anne-Bine, Grońska-Pęski, Marta, Shoag, Jonathan E., Evrony, Gilad D., Parsons, Heather A., Mayer, Erica L., Makrigiorgos, G. Mike, Golub, Todd R., Adalsteinsson, Viktor A.

Volltext

TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer von CAREY, Lisa A, RUGO, Hope S, WOLFF, Antonio C, HOBDAY, Timothy J, IVANOVA, Anastasia, CHIU, Wing-Keung, FERRARO, Madlyn, BURROWS, Emily, BERNARD, Philip S, HOADLEY, Katherine A, PEROU, Charles M, WINER, Eric P, MARCOM, P. Kelly, MAYER, Erica L, ESTEVA, Francisco J, MA, Cynthia X, LIU, Minetta C, STORNIOLO, Anna Maria, RIMAWI, Mothaffar F, FORERO-TORRES, Andres

Volltext

Congestive Heart Failure Risk in Patients With Breast Cancer Treated With Bevacizumab von CHOUEIRI, Toni K, MAYER, Erica L, JE, Youjin, ROSENBERG, Jonathan E, NGUYEN, Paul L, AZZI, Georges R, BELLMUNT, Joaquim, BURSTEIN, Harold J, SCHUTZ, Fabio A. B

Volltext

Effect of the LIVESTRONG at the YMCA exercise program on physical activity, fitness, quality of life, and fatigue in cancer survivors von Irwin, Melinda L., Cartmel, Brenda, Harrigan, Maura, Li, Fangyong, Sanft, Tara, Shockro, Laura, O'Connor, Keelin, Campbell, Nancy, Tolaney, Sara M., Mayer, Erica L., Yung, Rachel, Freedman, Rachel A., Partridge, Ann H., Ligibel, Jennifer A.

Volltext

The dilemma of selecting a first line CDK4/6 inhibitor for hormone receptor-positive/HER2-negative metastatic breast cancer von Grinshpun, Albert, Tolaney, Sara M., Burstein, Harold J., Jeselsohn, Rinath, Mayer, Erica L.

Volltext

Clinical characterization, prognostic, and predictive values of HER2-low in patients with early breast cancer in the PALLAS trial (ABCSG-42/AFT-05/BIG-14-13/PrE0109) von Nader-Marta, Guilherme, Singer, Christian, Hlauschek, Dominik, DeMichele, Angela, Tarantino, Paolo, de Azambuja, Evandro, Pfeiler, Georg, Martin, Miguel, Balko, Justin M, Nowecki, Zbigniew, Balic, Marija, Brufsky, Adam M, Chan, Arlene, Morris, Patrick G, Haddad, Tufia, Loibl, Sibylle, Liu, Yuan, Soelkner, Lidija, Fesl, Christian, Mayer, Erica L, Gnant, Michael

Volltext

Cardiac Toxicity From Systemic Cancer Therapy: A Comprehensive Review von Curigliano, Giuseppe, Mayer, Erica L, Burstein, Harold J, Winer, Eric P, Goldhirsch, Aron

Volltext

Ribociclib Plus Trastuzumab in Advanced HER2-Positive Breast Cancer: Results of a Phase 1b/2 Trial von Goel, Shom, Pernas, Sonia, Tan-Wasielewski, Zhenying, Barry, William T., Bardia, Aditya, Rees, Rebecca, Andrews, Chelsea, Tahara, Rie Kawabori, Trippa, Lorenzo, Mayer, Erica L., Winer, Eric P., Spring, Laura M., Tolaney, Sara M.

Volltext

What’s the reality for CDK4/6 inhibitors: Clinical trials or real‐world evidence? von Trapani, Dario, Mayer, Erica L.

Volltext

Targeting Breast Cancer with CDK Inhibitors von Mayer, Erica L.

Volltext

Breast Cancer Survivors' Perceptions of Survivorship Care Options von MAYER, Erica L, GROPPER, Adrienne B, NEVILLE, Bridget A, PARTRIDGE, Ann H, CAMERON, Danielle B, WINER, Eric P, EARLE, Craig C

Volltext

Partnering Teams to Optimize the Care of Patients With HER2-Positive Breast Cancer von Mayer, Erica L.

Volltext

Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update von Andre, Fabrice, Ismaila, Nofisat, Allison, Kimberly H, Barlow, William E, Collyar, Deborah E, Damodaran, Senthil, Henry, N Lynn, Jhaveri, Komal, Kalinsky, Kevin, Kuderer, Nicole M, Litvak, Anya, Mayer, Erica L, Pusztai, Lajos, Raab, Rachel, Wolff, Antonio C, Stearns, Vered

Volltext

Contrary Effects of the Receptor Tyrosine Kinase Inhibitor Vandetanib on Constitutive and Flow-Stimulated Nitric Oxide Elaboration in Humans von Mayer, Erica L, Dallabrida, Susan M, Rupnick, Maria A, Redline, Whitney M, Hannagan, Keri, Ismail, Nesreen S, Burstein, Harold J, Beckman, Joshua A

Volltext

Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502 von Stover, Daniel G., Salgado, Roberto, Savenkov, Oleksander, Ballman, Karla, Mayer, Erica L., Magbanua, Mark Jesus M., Loi, Sherene, Vater, Mark, Glover, Kristyn, Watson, Mark, Wen, Yujia, Symmans, W. Fraser, Perou, Charles, Carey, Lisa A., Partridge, Ann H., Rugo, Hope S.

Volltext

Prognosis of pregnancy-associated breast cancer von Lee, Guek Eng, Mayer, Erica L., Partridge, Ann

Volltext

Early and late long-term effects of adjuvant chemotherapy von Mayer, Erica L

Volltext